Overview

Our primary objective is to evaluate the ability of Boulder Care's telehealth-platform to create the necessary paradigmatic shift in Opioid Use Disorder (OUD) treatment to reach vulnerable populations, with targets that support both equitable and culturally-specific OUD treatment as well as business profitability.

Eligibility

Inclusion Criteria:

• History of Opioid Use Disorder (OUD)
• Starting OUD treatment with buprenorphine, or within 45 days of starting or restarting this medication
• Speak and understand English

Exclusion Criteria:

• History of allergic reaction to buprenorphine
• Plans to move out of a Boulder Care-affiliated state site in the next 12 months (precluding continuation of care)
• Untreated mental or medical health conditions that, in the opinion of the participant, would preclude study participation